Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1990-05-25
1992-07-21
Rollins, John W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 46, A51K 3170
Patent
active
051322927
ABSTRACT:
Hepatitis viral infections are efficaciously treated with mismatched dsRNAs, notably rI.multidot.r(C.sub.11-14,.sup.U).sub.n, alone or in combination with one or more of ganciclovir, coumermycin Al, dideoxyinosine or its nucleoside analogs.
REFERENCES:
patent: 4950652 (1990-08-01), Carter
patent: 4963532 (1990-10-01), Carter
Morbidity and Mortality Report 31(24): 317.
Beaslely, R. P. et al:Hepatocellular carcinoma and Lanacet 2:1129, 1981.
Shafritz et al Integration of hepatitis B . . . specimens New England Journal of Medicine 305:1067, 1981.
Zaman et al Ris factors in Development . . . cirrhosis Lancet 1:1357, 1985.
kuhns et al New Assay for quantitative . . . human serum Zuckerman 45th ed. Alan R. Liss N.Y. 1988.
Scullard et al Antiviral treatment of chronic . . . infection Hepatology 1:228-232, 1981.
Scullard et al Antiviral treatment of chronic . . . to treatment Hepatology 2:39-49, 1982.
HEM Research, Inc.
Rollins John W.
LandOfFree
Treatment of viral hepatitis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of viral hepatitis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of viral hepatitis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-843399